Global and United States Monoclonal Antibody Therapeutics Market Report & Forecast 2022-2028

Global and United States Monoclonal Antibody Therapeutics Market Report & Forecast 2022-2028

Table of Contents
1 Study Coverage
1.1 Monoclonal Antibody Therapeutics Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million) Introduction
1.2 Global Monoclonal Antibody Therapeutics Outlook 2017 VS 2022 VS 2028
1.2.1 Global Monoclonal Antibody Therapeutics Market Size for the Year 2017-2028
1.2.2 Global Monoclonal Antibody Therapeutics Market Size for the Year 2017-2028
1.3 Monoclonal Antibody Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Monoclonal Antibody Therapeutics in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Monoclonal Antibody Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Monoclonal Antibody Therapeutics Market Dynamics
1.4.1 Monoclonal Antibody Therapeutics Industry Trends
1.4.2 Monoclonal Antibody Therapeutics Market Drivers
1.4.3 Monoclonal Antibody Therapeutics Market Challenges
1.4.4 Monoclonal Antibody Therapeutics Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Monoclonal Antibody Therapeutics by Type
2.1 Monoclonal Antibody Therapeutics Market Segment by Type
2.1.1 Humanized Antibody
2.1.2 Human Mouse Chimeric Antibody
2.2 Global Monoclonal Antibody Therapeutics Market Size by Type (2017, 2022 & 2028)
2.3 Global Monoclonal Antibody Therapeutics Market Size by Type (2017-2028)
2.4 United States Monoclonal Antibody Therapeutics Market Size by Type (2017, 2022 & 2028)
2.5 United States Monoclonal Antibody Therapeutics Market Size by Type (2017-2028)
3 Monoclonal Antibody Therapeutics by Application
3.1 Monoclonal Antibody Therapeutics Market Segment by Application
3.1.1 Cancer
3.1.2 Autoimmune Diseases
3.1.3 Infection
3.1.4 Hematological Diseases
3.1.5 Ophthalmological Diseases
3.1.6 Others
3.2 Global Monoclonal Antibody Therapeutics Market Size by Application (2017, 2022 & 2028)
3.3 Global Monoclonal Antibody Therapeutics Market Size by Application (2017-2028)
3.4 United States Monoclonal Antibody Therapeutics Market Size by Application (2017, 2022 & 2028)
3.5 United States Monoclonal Antibody Therapeutics Market Size by Application (2017-2028)
4 Global Monoclonal Antibody Therapeutics Competitor Landscape by Company
4.1 Global Monoclonal Antibody Therapeutics Market Size by Company
4.1.1 Top Global Monoclonal Antibody Therapeutics Companies Ranked by Revenue (2021)
4.1.2 Global Monoclonal Antibody Therapeutics Revenue by Player (2017-2022)
4.2 Global Monoclonal Antibody Therapeutics Concentration Ratio (CR)
4.2.1 Monoclonal Antibody Therapeutics Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Monoclonal Antibody Therapeutics in 2021
4.2.3 Global Monoclonal Antibody Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Monoclonal Antibody Therapeutics Headquarters, Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.1 Global Monoclonal Antibody Therapeutics Headquarters and Area Served
4.3.2 Global Monoclonal Antibody Therapeutics Companies Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Monoclonal Antibody Therapeutics Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Monoclonal Antibody Therapeutics Market Size by Company
4.5.1 Top Monoclonal Antibody Therapeutics Players in United States, Ranked by Revenue (2021)
4.5.2 United States Monoclonal Antibody Therapeutics Revenue by Players (2020, 2021 & 2022)
5 Global Monoclonal Antibody Therapeutics Market Size by Region
5.1 Global Monoclonal Antibody Therapeutics Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Monoclonal Antibody Therapeutics Market Size by Region (2017-2028)
5.2.1 Global Monoclonal Antibody Therapeutics Market Size by Region: 2017-2022
5.2.2 Global Monoclonal Antibody Therapeutics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Monoclonal Antibody Therapeutics Market Size YoY Growth 2017-2028
6.1.2 North America Monoclonal Antibody Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Monoclonal Antibody Therapeutics Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Monoclonal Antibody Therapeutics Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Monoclonal Antibody Therapeutics Market Size YoY Growth 2017-2028
6.3.2 Europe Monoclonal Antibody Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Monoclonal Antibody Therapeutics Market Size YoY Growth 2017-2028
6.4.2 Latin America Monoclonal Antibody Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Monoclonal Antibody Therapeutics Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Monoclonal Antibody Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Bayer
7.1.1 Bayer Company Details
7.1.2 Bayer Business Overview
7.1.3 Bayer Monoclonal Antibody Therapeutics Introduction
7.1.4 Bayer Revenue in Monoclonal Antibody Therapeutics Business (2017-2022)
7.1.5 Bayer Recent Development
7.2 F. Hoffmann-La Roche
7.2.1 F. Hoffmann-La Roche Company Details
7.2.2 F. Hoffmann-La Roche Business Overview
7.2.3 F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Introduction
7.2.4 F. Hoffmann-La Roche Revenue in Monoclonal Antibody Therapeutics Business (2017-2022)
7.2.5 F. Hoffmann-La Roche Recent Development
7.3 Pfizer
7.3.1 Pfizer Company Details
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Monoclonal Antibody Therapeutics Introduction
7.3.4 Pfizer Revenue in Monoclonal Antibody Therapeutics Business (2017-2022)
7.3.5 Pfizer Recent Development
7.4 Sanofi
7.4.1 Sanofi Company Details
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Monoclonal Antibody Therapeutics Introduction
7.4.4 Sanofi Revenue in Monoclonal Antibody Therapeutics Business (2017-2022)
7.4.5 Sanofi Recent Development
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Company Details
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Monoclonal Antibody Therapeutics Introduction
7.5.4 GlaxoSmithKline Revenue in Monoclonal Antibody Therapeutics Business (2017-2022)
7.5.5 GlaxoSmithKline Recent Development
7.6 Merck
7.6.1 Merck Company Details
7.6.2 Merck Business Overview
7.6.3 Merck Monoclonal Antibody Therapeutics Introduction
7.6.4 Merck Revenue in Monoclonal Antibody Therapeutics Business (2017-2022)
7.6.5 Merck Recent Development
7.7 Novartis
7.7.1 Novartis Company Details
7.7.2 Novartis Business Overview
7.7.3 Novartis Monoclonal Antibody Therapeutics Introduction
7.7.4 Novartis Revenue in Monoclonal Antibody Therapeutics Business (2017-2022)
7.7.5 Novartis Recent Development
7.8 AbbVie
7.8.1 AbbVie Company Details
7.8.2 AbbVie Business Overview
7.8.3 AbbVie Monoclonal Antibody Therapeutics Introduction
7.8.4 AbbVie Revenue in Monoclonal Antibody Therapeutics Business (2017-2022)
7.8.5 AbbVie Recent Development
7.9 Amgen
7.9.1 Amgen Company Details
7.9.2 Amgen Business Overview
7.9.3 Amgen Monoclonal Antibody Therapeutics Introduction
7.9.4 Amgen Revenue in Monoclonal Antibody Therapeutics Business (2017-2022)
7.9.5 Amgen Recent Development
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Company Details
7.10.2 Johnson & Johnson Business Overview
7.10.3 Johnson & Johnson Monoclonal Antibody Therapeutics Introduction
7.10.4 Johnson & Johnson Revenue in Monoclonal Antibody Therapeutics Business (2017-2022)
7.10.5 Johnson & Johnson Recent Development
7.11 Bristol-Myers Squibb Company
7.11.1 Bristol-Myers Squibb Company Company Details
7.11.2 Bristol-Myers Squibb Company Business Overview
7.11.3 Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Introduction
7.11.4 Bristol-Myers Squibb Company Revenue in Monoclonal Antibody Therapeutics Business (2017-2022)
7.11.5 Bristol-Myers Squibb Company Recent Development
7.12 Biogen
7.12.1 Biogen Company Details
7.12.2 Biogen Business Overview
7.12.3 Biogen Monoclonal Antibody Therapeutics Introduction
7.12.4 Biogen Revenue in Monoclonal Antibody Therapeutics Business (2017-2022)
7.12.5 Biogen Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Monoclonal Antibody Therapeutics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Monoclonal Antibody Therapeutics Market Trends
Table 3. Monoclonal Antibody Therapeutics Market Drivers
Table 4. Monoclonal Antibody Therapeutics Market Challenges
Table 5. Monoclonal Antibody Therapeutics Market Restraints
Table 6. Global Monoclonal Antibody Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Monoclonal Antibody Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Monoclonal Antibody Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Monoclonal Antibody Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Monoclonal Antibody Therapeutics Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Monoclonal Antibody Therapeutics Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Monoclonal Antibody Therapeutics Revenue Share by Player, 2017-2022
Table 13. Global Monoclonal Antibody Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Monoclonal Antibody Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Therapeutics as of 2021)
Table 15. Top Players of Monoclonal Antibody Therapeutics in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Monoclonal Antibody Therapeutics Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Monoclonal Antibody Therapeutics Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Monoclonal Antibody Therapeutics Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Monoclonal Antibody Therapeutics Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Monoclonal Antibody Therapeutics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Monoclonal Antibody Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Monoclonal Antibody Therapeutics Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Monoclonal Antibody Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Monoclonal Antibody Therapeutics Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Monoclonal Antibody Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Monoclonal Antibody Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Monoclonal Antibody Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Bayer Company Details
Table 31. Bayer Business Overview
Table 32. Bayer Monoclonal Antibody Therapeutics Product
Table 33. Bayer Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million)
Table 34. Bayer Recent Development
Table 35. F. Hoffmann-La Roche Company Details
Table 36. F. Hoffmann-La Roche Business Overview
Table 37. F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Product
Table 38. F. Hoffmann-La Roche Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million)
Table 39. F. Hoffmann-La Roche Recent Development
Table 40. Pfizer Company Details
Table 41. Pfizer Business Overview
Table 42. Pfizer Monoclonal Antibody Therapeutics Product
Table 43. Pfizer Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million)
Table 44. Pfizer Recent Development
Table 45. Sanofi Company Details
Table 46. Sanofi Business Overview
Table 47. Sanofi Monoclonal Antibody Therapeutics Product
Table 48. Sanofi Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million)
Table 49. Sanofi Recent Development
Table 50. GlaxoSmithKline Company Details
Table 51. GlaxoSmithKline Business Overview
Table 52. GlaxoSmithKline Monoclonal Antibody Therapeutics Product
Table 53. GlaxoSmithKline Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million)
Table 54. GlaxoSmithKline Recent Development
Table 55. Merck Company Details
Table 56. Merck Business Overview
Table 57. Merck Monoclonal Antibody Therapeutics Product
Table 58. Merck Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million)
Table 59. Merck Recent Development
Table 60. Novartis Company Details
Table 61. Novartis Business Overview
Table 62. Novartis Monoclonal Antibody Therapeutics Product
Table 63. Novartis Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million)
Table 64. Novartis Recent Development
Table 65. AbbVie Company Details
Table 66. AbbVie Business Overview
Table 67. AbbVie Monoclonal Antibody Therapeutics Product
Table 68. AbbVie Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million)
Table 69. AbbVie Recent Development
Table 70. Amgen Company Details
Table 71. Amgen Business Overview
Table 72. Amgen Monoclonal Antibody Therapeutics Product
Table 73. Amgen Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million)
Table 74. Amgen Recent Development
Table 75. Johnson & Johnson Company Details
Table 76. Johnson & Johnson Business Overview
Table 77. Johnson & Johnson Monoclonal Antibody Therapeutics Product
Table 78. Johnson & Johnson Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million)
Table 79. Johnson & Johnson Recent Development
Table 80. Bristol-Myers Squibb Company Company Details
Table 81. Bristol-Myers Squibb Company Business Overview
Table 82. Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Product
Table 83. Bristol-Myers Squibb Company Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million)
Table 84. Bristol-Myers Squibb Company Recent Development
Table 85. Biogen Company Details
Table 86. Biogen Business Overview
Table 87. Biogen Monoclonal Antibody Therapeutics Product
Table 88. Biogen Revenue in Monoclonal Antibody Therapeutics Business (2017-2022) & (US$ Million)
Table 89. Biogen Recent Development
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
List of Figures
Figure 1. Monoclonal Antibody Therapeutics Product Picture
Figure 2. Global Monoclonal Antibody Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Monoclonal Antibody Therapeutics Market Size 2017-2028 (US$ Million)
Figure 4. United States Monoclonal Antibody Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Monoclonal Antibody Therapeutics Market Size 2017-2028 (US$ Million)
Figure 6. United States Monoclonal Antibody Therapeutics Market Share in Global 2017-2028
Figure 7. Monoclonal Antibody Therapeutics Report Years Considered
Figure 8. Product Picture of Humanized Antibody
Figure 9. Product Picture of Human Mouse Chimeric Antibody
Figure 10. Global Monoclonal Antibody Therapeutics Market Share by Type in 2022 & 2028
Figure 11. Global Monoclonal Antibody Therapeutics Market Size by Type (2017-2028) & (US$ Million)
Figure 12. Global Monoclonal Antibody Therapeutics Market Share by Type (2017-2028)
Figure 13. United States Monoclonal Antibody Therapeutics Market Share by Type in 2022 & 2028
Figure 14. United States Monoclonal Antibody Therapeutics Market Size by Type (2017-2028) & (US$ Million)
Figure 15. United States Monoclonal Antibody Therapeutics Market Share by Type (2017-2028)
Figure 16. Product Picture of Cancer
Figure 17. Product Picture of Autoimmune Diseases
Figure 18. Product Picture of Infection
Figure 19. Product Picture of Hematological Diseases
Figure 20. Product Picture of Ophthalmological Diseases
Figure 21. Product Picture of Others
Figure 22. Global Monoclonal Antibody Therapeutics Market Share by Application in 2022 & 2028
Figure 23. Global Monoclonal Antibody Therapeutics Market Size by Application (2017-2028) & (US$ Million)
Figure 24. Global Monoclonal Antibody Therapeutics Market Share by Application (2017-2028)
Figure 25. United States Monoclonal Antibody Therapeutics Market Share by Application in 2022 & 2028
Figure 26. United States Monoclonal Antibody Therapeutics Market Size by Application (2017-2028) & (US$ Million)
Figure 27. United States Monoclonal Antibody Therapeutics Market Share by Application (2017-2028)
Figure 28. North America Monoclonal Antibody Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 29. U.S. Monoclonal Antibody Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. Canada Monoclonal Antibody Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. Europe Monoclonal Antibody Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 32. Germany Monoclonal Antibody Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. France Monoclonal Antibody Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. U.K. Monoclonal Antibody Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Italy Monoclonal Antibody Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Russia Monoclonal Antibody Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. Asia-Pacific Monoclonal Antibody Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 38. China Monoclonal Antibody Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. Japan Monoclonal Antibody Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. South Korea Monoclonal Antibody Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. India Monoclonal Antibody Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Australia Monoclonal Antibody Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Taiwan Monoclonal Antibody Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Indonesia Monoclonal Antibody Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Thailand Monoclonal Antibody Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Malaysia Monoclonal Antibody Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Philippines Monoclonal Antibody Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Latin America Monoclonal Antibody Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 49. Mexico Monoclonal Antibody Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Brazil Monoclonal Antibody Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Argentina Monoclonal Antibody Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Middle East & Africa Monoclonal Antibody Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 53. Turkey Monoclonal Antibody Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Monoclonal Antibody Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 55. U.A.E Monoclonal Antibody Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 56. Bayer Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2017-2022)
Figure 57. F. Hoffmann-La Roche Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2017-2022)
Figure 58. Pfizer Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2017-2022)
Figure 59. Sanofi Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2017-2022)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2017-2022)
Figure 61. Merck Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2017-2022)
Figure 62. Novartis Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2017-2022)
Figure 63. AbbVie Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2017-2022)
Figure 64. Amgen Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2017-2022)
Figure 65. Johnson & Johnson Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2017-2022)
Figure 66. Bristol-Myers Squibb Company Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2017-2022)
Figure 67. Biogen Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2017-2022)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs